Call Us for Support
+91 9654860915
Finding access to medicine unapproved in your home country can feel overwhelming. We’re here to help you navigate the process, from your initial request to procurement coordination.
Submit your details and prescription to get started.Register today to get started on your medicine access journey.
Sourced directly from the authorized manufacturer network to ensure authenticity and quality.
Ready to proceed? Order Vistogard on our secure patient portal to submit your prescription, upload documents and track your approval status.
Supplied with complete CDSCO-approved import and customs documentation, including Form 12A & 12B, CDEC, GST Bill of Entry, Commercial Invoice, and Packing List.
Manufacturer / Innovator:
BTG International Inc. (a SERB company)
Regulatory Approval:
Your Trustworthy Partner For Named Patient Program
Over a decade of trusted expertise in Named Patient Access to innovative and life-saving medicines.
100% CDSCO-compliant processes ensuring safe, ethical, and responsible medicine access.
Medicines sourced from authorized manufacturers with full batch traceability.
EU-GDP compliant warehousing for secure, quality-controlled global distribution.
Temperature-controlled logistics ensuring safe, reliable, and timely medicine delivery.
Vistogard (uridine triacetate) is an emergency antidote for poisoning by two common chemotherapy medicines: fluorouracil (5-FU) and capecitabine. In the United States it is approved for adults and children:
It is not meant for routine side effects of chemotherapy, because it may also reduce how well the chemotherapy works. Its safety and benefit when started more than 96 hours after the chemotherapy have not been established. See our oncology medicines.
Uridine triacetate is turned into uridine in the body. Uridine competes with the toxic products of fluorouracil inside healthy cells, protecting them from damage and cell death.
Two open-label studies treated 135 patients who had a fluorouracil or capecitabine overdose or severe early toxicity. 96% survived to 30 days or went back to chemotherapy: 97% of the 117 overdose patients and 89% of the 18 patients with severe early toxicity.
Adults: one 10 g packet by mouth every 6 hours for 20 doses (5 days), with or without food. Children: 6.2 g per m² of body surface area per dose (never more than 10 g), every 6 hours for 20 doses.
Each dose is mixed with 3 to 4 ounces (about 90 to 120 mL) of soft food such as apple sauce, pudding or yoghurt, eaten within 30 minutes without chewing the granules, followed by at least 4 ounces of water. If the patient vomits within 2 hours of a dose, a full dose is given again. It can be given through a nasogastric or gastrostomy tube in patients with severe mouth sores or in a coma. All 20 doses should be taken, even if the patient feels better.
This information is not a treatment plan. For personalized medical advice, consult your doctor and refer to the full prescribing information.
Vistogard works best when started as soon as possible after the overdose or the first signs of severe toxicity, and the label covers use within 96 hours of the end of chemotherapy. Meanwhile, the hospital must continue full supportive care.
It should not be used to treat ordinary, non-emergency side effects of fluorouracil or capecitabine, because it may make the chemotherapy less effective.
Vistogard is generally well tolerated. In the studies, vomiting occurred in 10% of patients, nausea in 5% and diarrhoea in 3%. Only 2 of 135 patients stopped it because of side effects. The label lists no specific warnings or contraindications.
There is limited information on use in pregnancy and breastfeeding. The doctor weighs the emergency need against any possible risk.
This information is not a treatment plan. For personalized medical advice, consult your doctor and refer to the full prescribing information.
Vistogard is not sold in India, so it is imported for one named patient. Because it is an emergency antidote, speed matters more than for any other medicine we arrange.
As soon as an overdose or severe early toxicity is suspected, the treating doctor or family should call or WhatsApp us. We start the paperwork the same day.
We need the prescription for Vistogard (one full course is 20 packets for an adult), a short note from the doctor on the fluorouracil or capecitabine dose and timing, and the patient's ID. A pharmacist checks them at once.
The Vistogard price in India is quoted for one course of therapy (a carton of 20 packets), plus urgent freight and customs clearance.
We prepare the Form 12A application to CDSCO under Rule 36 of the Drugs and Cosmetics Rules. CDSCO states the Form 12B permit is usually issued within one to two days and stays valid for six months.
The granules are stored at room temperature, so no cold chain is needed. The shipment is booked on the fastest available route.
We deliver straight to the treating hospital.
We cannot promise this. The permit usually takes one to two working days once documents are complete, and the flight depends on stock at source. The treating team should continue full supportive care and not wait for the antidote. We tell you the expected arrival time with the quote.
No. Vistogard (uridine triacetate) has no marketing approval in India and is not sold in Indian pharmacies. We checked the published minutes of CDSCO's oncology and haematology expert committees from 2018 to November 2026, and uridine triacetate does not appear in them. It is also not authorised in the European Union, so supply comes from the United States. It can still be imported legally for a named patient under Rule 36, with a Form 12A application and a Form 12B permit.
Vistogard comes as orange-flavoured granules in 10 g single-dose packets. An adult course is 20 packets, sold as one carton; a 24-hour pack of 4 packets also exists. Children need a smaller weighed dose from each packet.
Not from an open online store, because a medicine without Indian approval cannot be sold off the shelf. The legal way is to send the prescription to NPP, and we arrange the permit and import in the patient's name.
Patients from Nepal, Bangladesh, Bhutan, Sri Lanka and the Gulf can also ask us, subject to each country's import rules. Read our guide to Indian import regulations for the full legal process.
Vistogard is supplied by BTG International, a SERB company, in the United States. As a Vistogard supplier in India under the named patient route, NPP buys it only through authorised channels and only after the patient's permit is issued, so every carton can be traced to one patient and one prescription.
Store at room temperature, 25°C, with short periods between 15°C and 30°C allowed. Keep packets sealed until use, and do not reuse granules left in an opened packet. We ship in insulated packs that protect against Indian summer heat; see our temperature-controlled shipping.
Nurses mix each dose with soft food and give it every 6 hours, day and night. For children, the dose is measured with a scale or a graduated teaspoon as shown in the label.
A registered pharmacist matches every order with the prescription and the permit before it leaves New Delhi.
For the Vistogard cost in India and current availability, contact NPP via WhatsApp at +91 98104 69557 | Toll-Free: 1800-1200-365 or email info@namedpatientprogram.com.
Vistogard is given in hospital, often in an intensive care or oncology ward, so we deliver straight to the treating hospital by the fastest route.
See how we arrange delivery of imported medicines to hospitals across India.
Our specialists are here to guide you through every step of the medicine access process.
Mail Us At:
info@namedpatientprogram.comContact Us:
+91 9654860915Send us a message